Vergote I, Van Nieuwenhuysen E, Casado A, Laenen A, et al. Randomized phase II BGOG/ENGOT-cx1 study of paclitaxel-carboplatin with or without nintedanib in first-line recurrent or advanced cervical cancer. Gynecol Oncol 2023;174:80-88.
PMID: 37167896